Request Demo
Last update 20 Mar 2025
Ceftazidime/Tazobactam Sodium
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms 头孢他啶他唑巴坦钠 |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Inactive Indication- |
Originator Organization- |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date China (15 Mar 2010), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC10H12N4NaO5S |
InChIKeyZUNWFYFXHGWFRA-QVUDESDKSA-N |
CAS Registry89785-84-2 |
View All Structures (2)
Related
4
Clinical Trials associated with Ceftazidime/Tazobactam SodiumCTR20140531
注射用头孢他啶他唑巴坦钠（5:1）治疗中、重度急性细菌性感染的 多中心、单臂、开放性、观察性研究
[Translation] A multicenter, single-arm, open-label, observational study of ceftazidime tazobactam sodium for injection (5:1) in the treatment of moderate to severe acute bacterial infections
CTR20140530
注射用头孢他啶他唑巴坦钠（5:1）治疗中、重度急性细菌性感染的 多中心、单臂、开放性、观察性研究
[Translation] A multicenter, single-arm, open-label, observational study of ceftazidime tazobactam sodium for injection (5:1) in the treatment of moderate to severe acute bacterial infections
CTR20140296
注射用头孢他啶他唑巴坦钠（3:1）治疗中、重度急性细菌感染的非随机、非对照、多中心、开放性Ⅳ期临床研究
[Translation] A non-randomized, non-controlled, multicenter, open-label phase IV clinical study of ceftazidime tazobactam sodium for injection (3:1) in the treatment of moderate to severe acute bacterial infections
100 Clinical Results associated with Ceftazidime/Tazobactam Sodium
Login to view more data
100 Translational Medicine associated with Ceftazidime/Tazobactam Sodium
Login to view more data
100 Patents (Medical) associated with Ceftazidime/Tazobactam Sodium
Login to view more data
100 Deals associated with Ceftazidime/Tazobactam Sodium
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Infectious Diseases | China | 01 Nov 2010 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Genitourinary tract infection | Phase 2 | China | 09 Feb 2012 | |
| Respiratory Tract Infections | Phase 2 | China | 09 Feb 2012 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free